Suppr超能文献

慢性肾脏病患者矿物质代谢紊乱的患病率及严重程度:一项来自印度一家三级护理医院的研究。

Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India.

作者信息

Vikrant Sanjay, Parashar Anupam

机构信息

Department of Nephrology, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.

Department of Community Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.

出版信息

Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):460-7. doi: 10.4103/2230-8210.183457.

Abstract

BACKGROUND

Disordered mineral metabolism is common complications of chronic kidney disease (CKD). However, there are limited data on the pattern of these disturbances in Indian CKD population.

MATERIALS AND METHODS

This was a prospective observational study of CKD-mineral and bone disorder (CKD-MBD) over a period of 3 years. The biochemical markers of CKD-MBD, namely, calcium, phosphorus, alkaline phosphatase, intact parathyroid hormone (iPTH), and 25-hydoxyvitamin Vitamin D3 (25OHD), were measured in newly diagnosed CKD Stage 3-5 and prevalent CKD Stage 5D adult patients.

RESULTS

A total of 462 patients of CKD Stage 3-5D were studied. The frequency of various biochemical abnormalities was hypocalcemia (23.8%), hypercalcemia (5.4%), hypophosphatemia (2.8%), hyperphosphatemia (55.4%), raised alkaline phosphatase (56.9%), secondary hyperparathyroidism (82.7%), and hypoparathyroidism (1.5%). 25OHD was done in 335 (72.5%) patients and 90.4% were found to have Vitamin D deficiency. About 70.6% of the patients had iPTH levels were above kidney disease outcomes quality initiative (KDOQI) target range. Nondiabetic CKD as compared to diabetic CKD had a higher alkaline phosphatase (P = 0.016), a higher iPTH (P = 0.001) a higher proportion of patients with iPTH above KDOQI target range (P = 0.09), and an elevated alkaline phosphatase (P = 0.004). The 25OHD levels were suggestive of severe Vitamin D deficiency in 33.7%, Vitamin D deficiency in 45.4%, and Vitamin D insufficiency in 11.3% patients. There was a significant positive correlation between iPTH with alkaline phosphatase (r = 0.572, P = 0.001), creatinine (r = 0.424, P = 0.001), and phosphorus (r = 0.241, P = 0.001) and a significant negative correlation with hemoglobin (r = -0.325, 0.001), age (r = -0.169, P = 0.002), and 25OHD (r = -0.126, P = 0.021). On multivariate logistic regression analysis, an elevated alkaline phosphatase was a significant predictor of hyperparathyroidism (odds ratio 9.7, 95% confidence interval 4.9-19.2, P = 0.001).

CONCLUSIONS

There was a high prevalence of CKD-MBD in Indian CKD patients. CKD-MBD is more common and more severe and has an early onset as compared to the western populations.

摘要

背景

矿物质代谢紊乱是慢性肾脏病(CKD)常见的并发症。然而,关于印度CKD患者中这些紊乱模式的数据有限。

材料与方法

这是一项为期3年的CKD - 矿物质和骨代谢紊乱(CKD - MBD)前瞻性观察研究。在新诊断的CKD 3 - 5期和CKD 5D期成年患者中,测量了CKD - MBD的生化标志物,即钙、磷、碱性磷酸酶、全段甲状旁腺激素(iPTH)和25 - 羟维生素D3(25OHD)。

结果

共研究了CKD 3 - 5D期的462例患者。各种生化异常的发生率为低钙血症(23.8%)、高钙血症(5.4%)、低磷血症(2.8%)、高磷血症(55.4%)、碱性磷酸酶升高(56.9%)、继发性甲状旁腺功能亢进(82.7%)和甲状旁腺功能减退(1.5%)。335例(72.5%)患者检测了25OHD,发现90.4%的患者存在维生素D缺乏。约70.6%的患者iPTH水平高于肾脏病预后质量倡议(KDOQI)目标范围。与糖尿病CKD相比,非糖尿病CKD患者碱性磷酸酶水平更高(P = 0.016)、iPTH水平更高(P = 0.001)、iPTH高于KDOQI目标范围的患者比例更高(P = 0.09)以及碱性磷酸酶升高(P = 0.004)。25OHD水平提示33.7%的患者为严重维生素D缺乏,45.4%为维生素D缺乏,11.3%为维生素D不足。iPTH与碱性磷酸酶(r = 0.572,P = 0.001)、肌酐(r = 0.424,P = 0.001)和磷(r = 0.241,P = 0.001)呈显著正相关,与血红蛋白(r = -0.325,P = 0.001)、年龄(r = -0.169,P = 0.002)和25OHD(r = -0.126,P = 0.021)呈显著负相关。多因素逻辑回归分析显示,碱性磷酸酶升高是甲状旁腺功能亢进的显著预测因素(比值比9.7,95%置信区间4.9 - 19.2,P = 0.001)。

结论

印度CKD患者中CKD - MBD的患病率较高。与西方人群相比,CKD - MBD更常见、更严重且发病更早。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3d8/4911834/99044f2713ef/IJEM-20-460-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验